AI-Designed Molecular Sensors Could Transform Early Cancer Detection
Advances could signal changes for clinical laboratories and at-home testing
Already a member? Log in here
Rise of Capillary Electrophoresis in the Clinical Laboratory
The technology has moved from niche to practical for routine diagnostics
Already a member? Log in here
Diagnostics Pipeline: MyOme and Artera Launch New Tests for Prostate Cancer Risk
The two assays identify threats prior to prostate cancer being diagnosed and after it has undergone extensive treatment, respectively
Already a member? Log in here
PAMA Delay Proposed Until 2027 Under a New Federal Spending Bill
However, attorney Danielle Sloane urges labs to be proactive about potential PAMA reporting requirements on Jan. 31 if the bill doesn’t pass quickly
Already a member? Log in here
FDA Watch: Truvian Health Receives Initial FDA Clearance for 34-Test Platform
San Diego-based healthcare diagnostics company is trying to succeed where Theranos failed
Already a member? Log in here
Dx Deals: Seeking Expanded MRD Testing, Natera Acquires Foresight Diagnostics in $450M Deal
Agreement is part of the Natera’s aggressive growth model as it strives to turn a profit
Already a member? Log in here
ACLA Head Pushes RESULTS Act Passage During House Subcommittee Testimony
Better clinical laboratory test data reporting would allow ‘Medicare rates to be more appropriately set,’ says Susan Van Meter
Already a member? Log in here
FDA Watch: Agency Takes Steps to Downgrade Some Nucleic Acid-Based Tests to Class II
The change is expected to dramatically cut the costs of developing new tests
Already a member? Log in here
Genetic Testing Kickback Scheme Results in 46-Month Prison Term
Federal prosecutors continue to target situations where third-party recruiters influence test ordering
Already a member? Log in here
Dx Deals: Labs Exploring Cryptocurrency Share Their Plans
Know Labs and ProPhase Laboratories discussed plans that in part involve digital currencies
Already a member? Log in here